Atlas Trials

Immunogenicity Trial of 3 Influenza Vaccines

Clinical trial NCT05479370 · COMPLETED

Trial details

NCT number
NCT05479370
Sponsor
Tan Tock Seng Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza Vaccination
Start date
2022-09-29
Primary completion
2023-04-14
Enrollment
366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.